STOCK TITAN

Corvus Pharmaceuticals, Inc. (CRVS) Free Cash Flow by Year

CRVS

Corvus Pharmaceuticals, Inc. recorded an outflow of $33.0M in free cash flow in fiscal year 2025. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to an outflow of $45.2M in free cash flow. The table below carries 12 fiscal years, from 2014 to 2025, and the quarters Corvus Pharmaceuticals, Inc. has filed alongside them.

FY2025 annual
Free Cash Flow -$33.0M
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

CRVS Free Cash Flow by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY25DEF 14AFY24DEF 14AFY23DEF 14AFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-K
Free Cash Flow-$45.2M-$33.0MN/A-$24.0M+12.2%-$27.3M+25.7%-$36.7M-5.4%-$34.9M+6.7%-$37.3M+9.7%-$41.3M+11.0%-$46.5M-54.6%-$30.1M-129.9%-$13.1MN/A

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

CRVS Free Cash Flow by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Free Cash Flow-$16.0M-171.3%-$10.5M-26.1%-$9.2M-$9.6M-$5.9M-$8.3MN/AN/AN/AN/A-$5.2M+31.5%-$5.4M+24.5%

What free cash flow means

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.

More Corvus Pharmaceuticals, Inc. financials

Frequently Asked Questions

What was Corvus Pharmaceuticals, Inc.'s free cash flow in fiscal year 2025?

Corvus Pharmaceuticals, Inc. recorded an outflow of $33.0M in free cash flow in fiscal year 2025.

What is Corvus Pharmaceuticals, Inc.'s free cash flow over the last twelve months?

Corvus Pharmaceuticals, Inc. (CRVS) reported an outflow of $45.2M in free cash flow over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

What was Corvus Pharmaceuticals, Inc.'s free cash flow in the most recent quarter?

Corvus Pharmaceuticals, Inc. (CRVS) reported -$16.0M in free cash flow in Q2 2026. This represents a decrease of 171.3% from the same quarter a year earlier.

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Corvus Pharmaceuticals, Inc. (CRVS) reported on that line in every period on record.